{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:27:12Z","timestamp":1793896032378,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH004"],"award-info":[{"award-number":["ZR2023MH004"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MH261"],"award-info":[{"award-number":["ZR2023MH261"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110238","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:41:24Z","timestamp":1783600884000},"page":"110238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Radiosensitization effect of PD-L1-targeted small molecules with direct antitumor activity on non-small cell lung Cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Cun","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.bioorg.2026.110238_bb0005","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.3390\/ijms241914614","article-title":"Regulation of Ferroptosis in lung adenocarcinoma","volume":"24","author":"Wei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110238_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.sult.2018.11.009","article-title":"Spectrum of lung adenocarcinoma","volume":"40","author":"Hutchinson","year":"2019","journal-title":"Semin. Ultrasound CT MR"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110238_bb0015","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.3390\/ijms241713302","article-title":"MiRNAs in lung adenocarcinoma: role, diagnosis, prognosis, and therapy","volume":"24","author":"Song","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110238_bb0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rxeng.2024.11.003","article-title":"Lung adenocarcinoma: characteristic radiological presentations","volume":"66","author":"Robles G\u00f3mez","year":"2024","journal-title":"Radiolog\u00eda (English Edition)"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110238_bb0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110238_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.12.654","article-title":"PD-L1 on mast cells suppresses effector CD8+ T-cell activation in the skin in murine contact hypersensitivity","volume":"148","author":"Hirano","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","article-title":"Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110238_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121516","article-title":"Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy","volume":"284","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110238_bb0050","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232101","article-title":"Radiotherapy and immunology","volume":"221","author":"Wang","year":"2024","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110238_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.04.019","article-title":"YTHDF2 inhibition potentiates radiotherapy antitumor efficacy","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0060","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1038\/s41467-023-39958-5","article-title":"Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1","volume":"14","author":"Gao","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110238_bb0065","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.2147\/CMAR.S279978","article-title":"MicroRNA-200c nanoparticles sensitized gastric Cancer cells to radiotherapy by regulating PD-L1 expression and EMT","volume":"27","author":"Qian","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110238_bb0070","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1021\/acs.jmedchem.0c00574","article-title":"Discovery of novel resorcinol Dibenzyl ethers targeting the programmed cell Death-1\/programmed cell death-ligand 1 interaction as potential anticancer agents","volume":"63","author":"Cheng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110238_bb0075","series-title":"PubChem Compound Summary for CID 126843234, N'-[[2-methoxy-6-[(2-methyl-3-phenylphenyl)methoxy]pyridin-3-yl]methyl]ethane-1,2-diamine","author":"National Center for Biotechnology Information","year":"2025"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acsmedchemlett.3c00306","article-title":"Solubilizer tag effect on PD-L1\/inhibitor binding properties for m-Terphenyl derivatives","volume":"15","author":"Surmiak","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110238_bb0085","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1158\/0008-5472.CAN-21-2076","article-title":"Tumor intrinsic PD-L1 promotes DNA repair in distinct cancers and suppresses PARP inhibitor-induced synthetic lethality","volume":"82","author":"Kornepati","year":"2022","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110238_bb0090","first-page":"34","article-title":"A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance","volume":"24","author":"Li","year":"2022","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110238_bb0095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110238_bb0100","first-page":"495","article-title":"PD-1\/PD-L1 interaction regulates BCL2, KI67, BAX, and CASP3, altering proliferation, survival, and apoptosis in acute myeloid leukemia","volume":"22","author":"Soltani","year":"2023","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"625","key":"10.1016\/j.bioorg.2026.110238_bb0105","article-title":"Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response","volume":"10","author":"Ma","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2026.110238_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251406931","article-title":"Combining radiation and anti-PD-L1 enhances the antitumor activity in colorectal cancer via IFN-\u03b3-dependent activation of STAT1","volume":"24","author":"Yang","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"issue":"34","key":"10.1016\/j.bioorg.2026.110238_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202502811","article-title":"Quantitative tracking of apoptotic Caspase-3 in vivo for early evaluation of radiation therapy efficacy","volume":"64","author":"Wu","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110238_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4161\/auto.6058","article-title":"Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer","volume":"4","author":"Kim","year":"2008","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110238_bb0125","doi-asserted-by":"crossref","DOI":"10.1177\/00368504251343177","article-title":"\u03b1B-crystallin enhances radioresistance in basal-like breast cancer cells by suppressing caspase-3 activation","volume":"108","author":"Yuan","year":"2025","journal-title":"Sci. Prog."},{"key":"10.1016\/j.bioorg.2026.110238_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115663","article-title":"Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3\/NF-kB\/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea","volume":"168","author":"de Carvalho","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110238_bb0135","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1096\/fj.06-7827com","article-title":"Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion","volume":"21","author":"Nicolas","year":"2007","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2009.12.014","article-title":"The clinical significance of the tumor cell D2-40 immunoreactivity in non-small cell lung cancer","volume":"70","author":"Kadota","year":"2010","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110238_bb0145","article-title":"Therapeutic implications of tumor microenvironment in lung Cancer: focus on immune checkpoint blockade","volume":"7","author":"Genova","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","article-title":"Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer","volume":"17","author":"Cheng","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110238_bb0160","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"332","key":"10.1016\/j.bioorg.2026.110238_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.02.003","article-title":"X-ray-responsive polypeptide nanogel for concurrent chemoradiotherapy","volume":"10","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/j.bioorg.2026.110238_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70123","article-title":"Comparative efficacy of PD-1 inhibitor-based neoadjuvant chemoimmunotherapy regimens for resectable stage II-IIIa NSCLC: a real-world retrospective study","volume":"16","author":"Yan","year":"2025","journal-title":"Thorac. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110238_bb0175","first-page":"840","article-title":"Trattamento integrato radio-chemio-chirurgico nel carcinoma polmonare non a piccole cellule N2 [RAdio-chemo-surgical combined treatment of non-small cell lung carcinoma N2]","volume":"85","author":"Rovea","year":"1993","journal-title":"Radiol. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110238_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110238_bb0185","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1158\/1078-0432.CCR-20-0798","article-title":"PD-1\/PD-L1 blockers in NSCLC brain metastases: challenging paradigms and clinical practice","volume":"26","author":"Eguren-Santamaria","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110238_bb0190","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.21873\/anticanres.12662","article-title":"Heterogeneity of PD-L1 expression and relationship with biology of NSCLC","volume":"38","author":"Bassanelli","year":"2018","journal-title":"Anticancer Res"},{"issue":"418","key":"10.1016\/j.bioorg.2026.110238_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.01.005","article-title":"Interactions between EGFR and PD-1\/PD-L1 pathway: implications for treatment of NSCLC","volume":"1","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110238_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17460441.2023.2171396","article-title":"Computational approaches for the design of modulators targeting protein-protein interactions","volume":"18","author":"Rehman","year":"2023","journal-title":"Expert Opin. Drug Discovery"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110238_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/ph18020174","article-title":"Repurposing FDA-approved agents to develop a prototype helicobacter pylori shikimate kinase (HPSK) inhibitor: a computational approach using virtual screening, MM-GBSA calculations, MD simulations, and DFT analysis","volume":"18","author":"Al Khzem","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110238_bb0210","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1039\/D4RA08245A","article-title":"Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1\/PD-L1 axis inhibition","volume":"15","author":"Sobral","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110238_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119984","article-title":"Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression","volume":"247","author":"Gurung","year":"2020","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110238_bb0220","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10528-023-10401-0","article-title":"CircDENND2D inhibits PD-L1-mediated non-small cell lung Cancer metastasis and immune escape by regulating miR-130b-3p\/STK11 Axis","volume":"61","author":"Chen","year":"2023","journal-title":"Biochem. Genet."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110238_bb0225","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4049\/jimmunol.2101175","article-title":"LIGHT (TNFSF14) Costimulation enhances myeloid cell activation and antitumor immunity in the setting of PD-1\/PD-L1 and TIGIT checkpoint blockade","volume":"209","author":"Yoo","year":"2022","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110238_bb0230","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1158\/2159-8290.CD-21-1156","article-title":"Characterization of INCB086550: a potent and novel small-molecule PD-L1 inhibitor","volume":"12","author":"Koblish","year":"2022","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110238_bb0235","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/cam4.3739","article-title":"Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110238_bb0240","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1002\/cam4.6195","article-title":"Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K\/AKT signaling can be reversed by anlotinib","volume":"12","author":"Gao","year":"2023","journal-title":"Cancer Med."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110238_bb0245","article-title":"Study of hepatitis E Virus-4 infection in human liver-chimeric, Immunodeficient, and immunocompetent mice","volume":"28","author":"Collignon","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0250","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/s41598-021-85329-9","article-title":"Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110238_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110238_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110238_bb0265","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:01:01Z","timestamp":1793894461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":53,"alternative-id":["S0045206826007741"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110238","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosensitization effect of PD-L1-targeted small molecules with direct antitumor activity on non-small cell lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110238"}}